Status:
COMPLETED
Implementation of Genomics in Substance Use Disorder Treatment
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cigarette smoking remains one of the leading causes of preventable death. Effective smoking cessation medications exist but use of these treatments is low, making it difficult for most to quit smoking...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Smoked combustible cigarettes in past 30 days
- Computer access for remote-based study visits
Exclusion
- Younger than 18 years of age
- No computer access
Key Trial Info
Start Date :
March 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04768114
Start Date
March 19 2021
End Date
December 7 2022
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110